Frozen embryos create planning risks for financial advisers

Financial advisers and wealth managers report more cases where assisted reproductive technology intersects with financial and estate planning. The main issues involve frozen embryos and other stored genetic material, who pays ongoing storage fees and how informal donor arrangements affect parentage and inheritance.

Heather Zack, senior vice president for Private Client Services at Carson Group, notes that “modern reproductive technology means that family planning documents are now financial planning documents.” Advisers say they increasingly discover inconsistencies between fertility clinic paperwork and clients’ estate or divorce documents.

State law varies on parentage and embryo control. Some states have adopted updated parentage statutes such as the Uniform Parentage Act; others rely on older rules. Courts often refer to clinic consent forms and embryo-disposition agreements when resolving disputes, and outcomes depend on how clearly those documents express the parties’ intentions. In the Vergara-Loeb dispute and in Kass v. Kass, advance written directions about embryo use were decisive in court decisions.

Advisers describe practical problems when paperwork is vague or contradictory. One adviser encountered a client who disclosed frozen embryos during a divorce and said she no longer wanted to pay storage fees. Advisers then needed to establish the former partner’s intent and whether state law would allow storage to end. The legal environment shifted in some states after the Supreme Court decision overturning Roe v. Wade, affecting how long reproductive material may be stored or used under state rules.

Risks differ by type of donor. When an individual uses a licensed sperm bank and the clinic follows standard procedures, donors are typically not treated as legal parents. The risk increases when clients use known donors or informal agreements outside a clinic. Without clear, legally enforceable donor agreements, a donor might later seek parental recognition, or a parent could face support claims if the agreement does not meet state requirements.

Advisers do not need to practice reproductive law, but they should identify potential conflicts early. Key questions include whether clients have embryos, eggs or sperm in storage; whether a former spouse, partner or donor holds any legal or practical claim to that material; and whether clinic forms match the client’s estate plan and instructions for future or posthumous conception. Advisers then arrange review by fertility counsel, estate lawyers and family-law attorneys to resolve inconsistencies.

After parentage and control are clarified, advisers and counsel typically update trusts, powers of attorney, guardianship provisions and beneficiary designations to reflect the client’s family plan. For clients who have wealth-transfer or charitable goals, tax planning and asset-location decisions are often adjusted once embryo-control and parentage questions are settled to avoid unintended results.

Advisers report that addressing clinic paperwork, donor agreements and estate documents together requires legal review and coordinated updates to financial records. That process can involve revising multiple documents to make instructions about disposition and parentage consistent across legal and financial files.